Hledání článků
Filtry
Zafrani L, Truffault L, Kreis H, et al. Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study. Am J Transplant 2009;9:1816–1825.
Cattran DC, Coppo R, Cook HT, et al., and Working Group of the International IgA Nephropathy Network and the Renal Pathology Society: The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009;76:534–545.
Sanna‑Cherchi S, Ravani P, Corbani V, Parodi S, Haupt R, Piaggio G, Innocenti ML, Somenzi D, Trivelli A, Caridi G, Izzi C, Scolari F, Mattioli G, Allegri L, Ghiggeri GM. Renal outcome in patients with congenital anomalies of the kidney and urinary tract. Kidney Int 2009;76:528–533.
Evenepoel P, van den Bergh B, Naesens M, de Jonge H, Mammens B, Claes K, Kuypers D, Vanrenterghem Y. Calcium metabolism in the early posttransplantation period. Clin J Am Soc Nephrol 2009;4:665–672.
Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, BeddhuS. Weight loss interventions in chronic kidney disease: a systemic review and meta‑analysis. Clin J Am Soc Nephrol 2009; doi 10.2215/CJN.00250409.
Trappe R, Hinrichs C, Appel U, Babel N, Reinke P, Neumayer HH, Budde K, Dreyling M, Dührsen U, Kliem V, Schüttrumpf S, Hauser IA, Mergenthaler HG, Schlattmann P, Anagnostopoulos I, Doerken B, Riess H. Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppression. Am J Transplant 2009;9:2331–2337.
Dlouhodobé zvýšení chuti k jídlu u malnutričních dialyzovaných pacientů při denním podávání ghrelinu
Ashby DR, Ford HE, Wynne KJ, et al. Sustained apetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int 2009;76:199–206.
Labriola L, Wallemacq P, Gulbis B, Jadoul M. The impact of the assay for measuring albumin on corrected (‘adjusted’) calcium concentrations. Nephrol Dial Transplant 2009;24:1834–1838.
Luan FL, Stuckey LJ, Park JM, Kaul D, Cibrik D, Ojo A. Six‑month prophylaxis is cost effective in transplant patients at high risk for cytomegalovirus infection. J Am Soc Nephrol 2009;20:2449–2458.
RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S. Intensity of continuous renal‑replacement therapy in critically ill patients. N Engl J Med 2009;361:1627–1638.
Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009;301:2445–2452.
Marcelli D, Marelli C, Richards N. Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey. Nephrol Dial Transplant 2009;12:3566–3572.
Maripuri S, Grande JP, Osborn TG, Fervenza FC, Matteson EL, Donadio JV, Hogan MC. Renal involvement in primary Sjögren’s syndrome: a clinicopathologic study. Clin J Am Soc Nephrol 2009;4:1423–1431.
Stel VS, Dekker FW, Ansell D, et al. Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transpl 2009;24:3175–3182.